^
Association details:
Biomarker:No biomarker
Cancer:Gastroesophageal Junction Adenocarcinoma
Drug:irinotecan (Topoisomerase I inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Esophageal and Esophagogastric Junction Cancers: Preferred regimens…Irinotecan.